Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

Pharmaceutical giant Pfizer say forewarned is forearmed when it comes to potentially spiking Covid numbers in the winter months

Newsroom.co.nz

Two million Brits have been taking antidepressants for five years or more

Brits' long-term dependence on anti-depressants has been laid bare as figures show a quarter of people using the drugs have been taking them for more than five years

Daily Mirror

Warren Entsch denies he helped LNP donor get Pfizer vaccine during supply crisis

Allegation raised in parliament that MP arranged for property developer Alex Sekler to travel to Torres Strait for Covid jab referred to state corruption watchdog

The Guardian - AU

From analysis to the latest developments in health,
read the most diverse news in one place.

MP denies quid pro quo over COVID-19 jab for donor

The federal health minister has accused Liberal MP Warren Enstch of allowing a wealthy donor to use a COVID-19 vaccine dose intended for Indigenous people.

AAP

COVID boosters should be updated to target XBB strain, US health advisers say

COVID-19 shots should be reformulated to target an XBB subvariant of the highly infectious omicron strain to provide the best protection during the U.S. fall and winter season, health regulators said.

Tribune News Service

Pfizer warns of a looming penicillin supply shortage

The shortage comes as there has been a steady increase in rates of syphilis since 2000. Inventory can start depleting as early as this month, Pfizer said.

WEKU

Pfizer Warns Of Potential Pediatric Antibiotic Shortage Amid Surge In Syphilis Infections

Pfizer Inc cautions about potential supply shortages for pediatric Bicillin L-A, an antibiotic for syphilis treatment.

Zenger

Read news from The Economist, FT, and more,
with one subscription

Lady Gaga raises eyebrows over paid partnership with Pfizer migraine drug

Singer is an ‘actual patient’ using the drug Nurtec ODT

The Independent UK

Should You Buy Into Pfizer (PFE) Today?

Despite a slowdown of Covid-19 vaccine sales in the last reported quarter, biopharmaceutical giant Pfizer (PFE) is positioned to deliver robust growth this year and beyond, thanks to the strength of its in-line products and expected near-term launches and revenue distribution from the recent acquisition. So, let’s find out if…

StockNews.com

Kerala CM invites Pfizer to open research centre at Digital Sciences Park in Thiruvananthapuram

Chief Minister Pinarayi Vijayan lobbied with representatives of Pfizer, a global pharmaceutical major, to start a research wing in Kerala.

The Hindu

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK

Which Pharma Stock is a Pick for June: Pfizer (PFE) or SNDL Inc. (SNDL)?

The pharmaceutical industry is known for its resilience during challenging economic times, primarily due to the inelastic demand for essential medicines. As the specter of a potential recession hangs over the market, let us analyze two leading players in the sector, Pfizer (PFE) and SNDL (SNDL), to find the better…

StockNews.com

The anti-vaxxer threat keeps spreading

With vaccines on the horizon, RSV could finally be preventable. But anti-vax misinfo could get in the way

Salon

Next COVID vax might drop OG strain

Scientists debate the benefits of bivalent and monovalent shots

Salon

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

COVID pill Paxlovid gets full FDA approval after more than a year of emergency use

U.S. health regulators have given full approval to Pfizer’s COVID-19 pill Paxlovid

StockNews.com

Buy, Sell, or Hold: Pfizer Inc. (PFE)

Pfizer (PFE) continues to make significant strides in the pharmaceutical industry, given its recent acquisition and drug approvals. Is the stock a buy, sell, or hold now? Keep reading to find out….

The Independent UK

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK

First shot to prevent RSV in infants moves one step closer to FDA approval

Respiratory illness kills hundreds of babies per year

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU

FDA advisers support approval of RSV vaccine to protect infants

At least 58,000 childern younger than 5 years old are hospitalized each year with RSV infections. A Pfizer vaccine given to pregnant people could help protect their infants from severe RSV illness.

The Independent UK

RSV vaccine for pregnant women protects their newborns but is it ready for US sale?

Federal health advisers are debating a first-of-its-kind RSV vaccine to protect newborns by immunizing their moms late in pregnancy

Barchart

Stocks Undercut as Little Progress is seen in U.S. Debt Ceiling Talks

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.63%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.01%, and the Nasdaq 100 Index ($IU ) (QQQ ) closed up +0.09%. Stock indexes Tuesday settled mixed, with the Dow Jones...

Barchart

Stocks Mixed as Debt Ceiling Talks Resume

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.16%. U.S. stocks this morning are mixed, with the Dow...

The Walrus

The Vaccine Problem

To better weather future pandemics, the way countries procure vaccines needs to change radically

The Conversation

Obesity speeds up loss of immunity from COVID vaccines – new research

COVID vaccines are very effective, but for some groups they don’t generate as strong an immune response. These groups include older adults and people with weakened immune systems, for example due to cancer or other medical conditions. They tend to already be at heightened risk from COVID.

The Conversation

FDA's approval of the world's first vaccine against RSV will offer a new tool in an old fight – 4 questions answered

The U.S. Food and Drug Administration approved the world’s first vaccine to prevent the respiratory infection RSV, short for respiratory syncytial virus, on May 3, 2023. The new shot represents six decades of starts and stops in the hunt for a vaccine to curb one of the most common winter…

1 … 23 24 25 26

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.